v3 Template
T

Telix Pharmaceuticals Limited

Biopharmaceuticals Melbourne, Australia and Indianapolis, US ~460 employees
Founded
--
Employees (Est.)
~460
23 leaders known
Total Funding
$200.0M
Funding Rounds
1
Last Funding
2024-06-05

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. The company aims to change the way cancer and rare diseases are found and treated by using targeted radiation to inform treatment decisions and deliver personalized therapy in areas of significant unmet medical need.

Products & Services

Illuccix®:A lead imaging agent approved by the FDA and TGA for use in the United States and Australia for prostate cancer imaging.
Gozellix®:An imaging agent mentioned alongside Illuccix®, with transitional pass-through status granted by CMS.
Clinical Pipeline:One of the most expansive, late-stage research portfolios of diagnostic and therapeutic molecularly targeted radiation (MTR) candidates globally, covering urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning.
ProstACT Global:A Phase III prostate cancer therapy trial currently underway.

Specialties

Radiopharmaceuticals Theranostics Urologic Oncology (Prostate and Kidney Cancer) Neuro-Oncology (Glioma) Musculoskeletal Oncology (Sarcoma) Bone Marrow Conditioning

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: IPO
T: -
FT: IPO
A: 200000000
MR: -
FA: 200 million
FAN: 200000000
D: 2024-06-05
FD: 2024-06-05
4 investors
IPO Latest
2024-06-05
$200.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

T

Tiffany Olson

Non-Executive Director and Chair

C

Christian Behrenbruch

Managing Director & Group Chief Executive Officer

M

Marie McDonald

Independent Non-Executive Director

M

Mark Nelson

Independent Non-Executive Director

J

Jann Skinner

Independent Non-Executive Director

G

Genevieve Ryan

Company Secretary

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

Telix Pharmaceuticals Limited Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceuticals
Company Size
~460 employees (est.)
Locations
Melbourne, Australia and Indianapolis, US
Melbourne, Australia and Indianapolis, United States
Melbourne, Australia +3 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro